
	Three Months Ended				Nine Months Ended
	October 3, 2025		September 27, 2024		October 3, 2025		September 27, 2024
	(In thousands, except share and per share data)
Computation of Net income (loss) per share from continuing operations - basic:
Net income (loss) from continuing operations attributable to Enovis Corporation(1)	$	(571,106)	$	(33,764)	$	(663,593)	$	(124,332)
Weighted-average shares of Common stock outstanding – basic	57,169,061		55,665,527		57,028,852		55,072,194
Net income (loss) per share from continuing operations – basic	$	(9.99)	$	(0.61)	$	(11.64)	$	(2.26)

Computation of Net income (loss) per share from continuing operations - diluted:
Net income (loss) from continuing operations attributable to Enovis Corporation(1)	$	(571,106)	$	(33,764)	$	(663,593)	$	(124,332)
Weighted-average shares of Common stock outstanding – basic	57,169,061		55,665,527		57,028,852		55,072,194
Net effect of potentially dilutive securities - stock options and restricted stock units	—		—		—		—
Weighted-average shares of Common stock outstanding – diluted	57,169,061		55,665,527		57,028,852		55,072,194
Net income (loss) per share from continuing operations – diluted	$	(9.99)	$	(0.61)	$	(11.64)	$	(2.26)

(1) Net income (loss) from continuing operations attributable to Enovis Corporation for the respective periods is calculated using Net income (loss) from continuing operations less the continuing operations component of the income attributable to noncontrolling interest, net of taxes.

The following table presents the potentially dilutive shares of Common stock from stock-based compensation awards excluded from the calculation of Weighted-average shares of Common stock outstanding – diluted as inclusion would be anti-dilutive in Net income (loss) per share (“Anti-dilutive shares”):

In conjunction with the Lima Acquisition, the Company agreed to a contingent issuance of 1,942,686 Contingent Acquisition Shares in two equal tranches within six and twelve months of the acquisition date upon the non-occurrence of certain future events, in each case subject to certain adjustments and conditions as provided for in the purchase agreement. The first tranche of Contingent Acquisition Shares was issued to the seller on July 16, 2024 and the second tranche was issued on January 15, 2025. The Contingent Acquisition Shares were only included in the weighted-average calculation of basic shares when there were no circumstances the shares would not be issued.